Event Calendar
Prev MonthPrev Month Next MonthNext Month
Psychopharmacological Treatment in Special Populations I I via NMSU
Saturday, February 18, 2023, 9:00 AM to Sunday, February 19, 2023, 6:00 PM CST
Category: Events

Psychopharmacological Treatment in Special Populations I | via NMSU
(13.5 Hours)
ONLINE

The Iowa Psychological Association is pleased to partner with New Mexico State University's Clinical Psychopharmacology Post- Doctoral Masters Degree Program to offer Continuing Education (CE) training to IPA members.

Topic:
Psychopharmacological Treatment in Special Populations I

Credit Hours: 13.5 CEUs (Provided by NMSU, Sponsored by APA) NMSU is approved by the American Psychological Association to sponsor continuing education for psychologists. NMSU maintains responsibility for the program and its content

Location: Online

Date/Time
February 18 - 19, 2023
9:00am - 6:00pm CST

Instructors:
Rick Barnett, Ph.D., MSCP

Cost
$300: IPA Member
$200: IPA Lifetime Member
$200: IPA ECP Member
$130: IPA Retired Member
$0: IPA Student Member
$450: Non-Member

About This Workshop

In this class we begin our study of psychopharmacological considerations and treatment in special populations, specifically treatment of elderly adults. Major topics include the aging process, measures of functioning in major organ systems, and response to drug treatments for a variety of psychiatric conditions. The prescription, management, and use of psychotropic medications will be discussed in the management of agitation, pain, sleep, and behavior disorders. The primary framework uses a multidisciplinary lens in the interest of patient-centered care. Issues regarding ethnicity, race, and cultural diversity, individual differences, rights, and values will be approached during our approach to the treatment of elderly populations as well as in all classes in clinical psychopharmacology. Ethical issues related to pharmacologic interventions with older adults will be explored, including end-of-life pain management and attention to Alzheimer’s/dementia


Learning Objectives

Participants will be able to:
  1. Assess the renal function of one elderly patient using a Glomerular Filtration Rate (GFR) calculator.
  2. Learn how to order and interpret one renal functioning laboratory study, then the most appropriate course of treatment for an elderly patient with major depressive disorder.
  3. Learn how order and interpret one hepatic functioning laboratory study, then the most appropriate course of treatment for an elderly patient with major depressive disorder.
  4. Calculate one Child-Turcotte-Pugh score of hepatic function for a patient.
  5. Appraise one elderly patient’s medication list.
  6. Calculate one Beers score for the patients’ medication list after primary appraisal.
  7. Analyze the patient’s Beers score to select an appropriate medication for four conditions: insomnia, psychosis, depression, and anxiety.
  8. Inventory three psychotropic medications that do not require a dose adjustment based on the patient’s GFR.
  9. Appraise an elderly patient’s current medication list using two screening tools: Screening Tool of Older People's prescriptions (STOPP) and Screening Tool to Alert to Right Treatment (START) criteria.
  10. Consistent with the STOPP/START guidelines, characterize and defend the one most appropriate medication for a patient experiencing delirium.
  11. Estimate one elderly patient’s vulnerability score using the Vulnerable Elders Survey 13th Edition (VES – 13).
  12. Differentiate three psychotropic medications that are hepatotoxic and should not be used in patients with cirrhosis.
  13. Compile the ten most common medical illnesses in the elderly.
  14. Based on evidence in peer-reviewed articles, justify use of two empirically validated Decision Support Tools (DST’s) used for the treatment of Late Life Depression (LLD).
  15. Defend a risk/benefit analysis with four of the following drug classes often used the elderly treatment populations: second-generation antipsychotic (SGA’s); Alzheimer/Dementia (AZD) prescriptions; hypnotics; and mood stabilizers.
  16. Evaluate the relationship between outcome and sponsorship in at least two studies, of the comparative efficacy of evidence based combined medicine (psychotropic medications and psychotherapy) researched in older adults.
  17. Develop expected dosage adjustments in four drug classes using with older treatment populations: benzodiazepines, Selective Serotonin Reuptake Inhibitors (SSRI’s), anticonvulsants, and hypnotics.
  18. Prepare a medication strategy for each of five patients in case vignettes presented during the class.

Click here to register


Course Materials and Continuing Education

NMSU will email registrants course materials, and a link to join the live training two business days before the training.

Upon completion of the training, NMSU will email registrants the training evaluation. Upon completion of the training evaluation, the NMSU will email the registrant the CE certificate.


Refund and Cancellation Policy

We understand, sometimes things come up!

IPA will offer a full refund to registrants who cancel their registration 7 days prior to an event/course. If a registrant would like to cancel their registration within 7 days of the event, no refund will be offered.


Contact: Suzanne Hull, [email protected]